After Touching 52-Week Low, Is ChipMOS TECHNOLOGIES INC. (IMOS)’s Near-Term Analysis Negative?

April 24, 2018 - By Henry Gaston

The stock of ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) hit a new 52-week low and has $13.11 target or 6.00 % below today’s $13.95 share price. The 7 months bearish chart indicates high risk for the $606.62M company. The 1-year low was reported on Apr, 24 by If the $13.11 price target is reached, the company will be worth $36.40 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock decreased 5.42% or $0.8 during the last trading session, reaching $13.95. About 52,340 shares traded. ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) has declined 9.04% since April 24, 2017 and is downtrending. It has underperformed by 20.59% the S&P500.

ChipMOS TECHNOLOGIES INC. researches, develops, makes, and sells high integration and high precision integrated circuits, and related assembly and testing services. The company has market cap of $606.62 million. The firm provides a range of back-end assembly and test services, including engineering test, wafer probing, and final test services, as well as lead frame and organic substrate based package assembly services for memory and logic/mixed-signal semiconductors; memory modules; and gold bumping, assembly, and test services for LCD and other flat-panel display driver semiconductors. It has a 117.23 P/E ratio. The Company’s semiconductors are used in personal computers; graphics applications, such as game consoles; communications equipment; mobile products comprising cellular handsets, tablets, and consumer electronic products; and display applications, such as flat-panel displays.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.